Imatinib and oedema peripheral Patient Reports February 11, 2012

Imatinib Side Effects Report #5993641-1
Imatinib side effect was reported by a Health Professional from AUSTRIA on Dec 09, 2008. Female patient, child 1 years of age, was diagnosed with glioma and was treated with Imatinib. After drug was administered, patient experienced the following side effects: hypernatraemia, oedema peripheral, weight increased. Imatinib dosage: 230 MG/M2/DAY. Patient died.

Imatinib Side Effects Report #4599286-2
Imatinib side effect was reported by a Health Professional from on Mar 02, 2005. Male patient, weighting 235.9 lb, was diagnosed with glioblastoma multiforme and was treated with Imatinib. After drug was administered, patient experienced the following side effects: disease progression, oedema peripheral, pulmonary embolism . Imatinib dosage: 400MG DAILY PO X 8 DAYS. During the same period patient was treated with TEMOZOLOMIDE, DECADRON, TEGRETOL, POTASSIUM CHLORIDE, TYLENOL PM, PREVACID, SINGULAIR, ALBUTEROL. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #5612643-8
Imatinib side effect was reported by a Pharmacist from UNITED STATES on Feb 01, 2008. Male patient, 81 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with Imatinib. After drug was administered, patient experienced the following side effects: myalgia, oedema peripheral, respiratory depression. Imatinib dosage: 400MG EVERY DAY PO. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #5411771-X
Imatinib side effect was reported by a Health Professional from UNITED STATES on Aug 07, 2007. Male patient, 70 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: ascites, cardiac failure congestive, dyspnoea, oedema peripheral. Imatinib dosage: 600 MG/DAY. Patient died.


Imatinib Side Effects Report #5202373-9
Imatinib side effect was reported by a Health Professional from SPAIN on Jan 03, 2007. Male patient, 66 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: blast crisis in myelogenous leukaemia, disease progression, epidermal necrosis, excessive granulation tissue, hyperplasia, lividity, lung infiltration, oedema peripheral, parakeratosis. Imatinib dosage: 100 TO 400 MG/DAY. During the same period patient was treated with IMATINIB MESYLATE, IMATINIB MESYLATE, IMATINIB MESYLATE, HYDROXYUREA. Patient died on 05/01/2003.

Imatinib Side Effects Report #5213542-6
Imatinib side effect was reported by a Health Professional from SPAIN on Jan 15, 2007. Male patient, 66 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: blast crisis in myelogenous leukaemia, disease progression, epidermal necrosis, excessive granulation tissue, hyperplasia, lividity, lung infiltration, oedema peripheral, parakeratosis. Imatinib dosage: 100 TO 400 MG/DAY. During the same period patient was treated with IMATINIB MESYLATE, IMATINIB MESYLATE, IMATINIB MESYLATE, HYDROXYUREA. Patient died on 05/01/2003.

Imatinib Side Effects Report #6091521-7
Imatinib side effect was reported by a Health Professional from AUSTRALIA on Feb 13, 2009. Male patient, 55 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: condition aggravated, diabetes mellitus, fall , fibrosis, inflammation, malaise, oedema peripheral, pyoderma gangrenosum, pyrexia. Imatinib dosage: unknown. During the same period patient was treated with PREDNISONE. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #5669598-X
Imatinib side effect was reported by a Health Professional from UNITED STATES on Mar 06, 2008. Male patient, 40 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: abasia, bone marrow oedema, discomfort, muscle swelling, oedema peripheral, pain in extremity. Imatinib dosage: 400 MG, BID. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #5843810-6
Imatinib side effect was reported by a Health Professional from UNITED STATES on July 31, 2008. Male patient, 40 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: abasia, bone marrow oedema, discomfort, dysstasia, muscle swelling, oedema peripheral, pain in extremity. Imatinib dosage: 400 MG, BID. Patient was hospitalized. Patient recovered.


Imatinib Side Effects Report #5670753-3
Imatinib side effect was reported by a Health Professional from UNITED STATES on Mar 06, 2008. Male patient, 36 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: erythema, fasciitis, myositis , oedema peripheral, pain in extremity, tenderness. Imatinib dosage: 400 MG, BID. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #5843179-7
Imatinib side effect was reported by a Health Professional from UNITED STATES on July 31, 2008. Male patient, 36 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: erythema, fasciitis, myositis , oedema peripheral, pain in extremity, tenderness. Imatinib dosage: 400 MG, BID. During the same period patient was treated with IMATINIB MESYLATE. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #5258416-X
Imatinib side effect was reported by a Pharmacist from UNITED STATES on Mar 06, 2007. Female patient, child 10 years of age, weighting 109.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: fatigue, hypotension, oedema peripheral, somnolence. Imatinib dosage: 300 MG PO DAILY. During the same period patient was treated with STRATTERA, CLONIDINE, PROTONIX, ZOFRAN, SEPTRA. Patient was hospitalized. Patient recovered.